Cargando…
Radionuclides in the management of thyroid cancer
Nuclear medicine imaging was born over 60 years ago with imaging of thyroid conditions. Most of our present imaging devices were developed for imaging of the thyroid and thyroid cancer. Millions of patients in over 100 countries have been diagnosed and treated for thyroid cancer using nuclear medici...
Autor principal: | Buscombe, J.R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-Med
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151327/ https://www.ncbi.nlm.nih.gov/pubmed/18083649 http://dx.doi.org/10.1102/1470-7330.2007.0029 |
Ejemplares similares
-
Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022) -
Ensuring effective and sustainable radionuclide delivery and its impact on the development of nuclear medicine in the developing world with special reference to Nigeria
por: Orunmuyi, T. Akintunde, et al.
Publicado: (2019) -
Radionuclide Imaging in Cancer Management
por: Maisey, Michael
Publicado: (1998) -
Current role of radionuclide imaging in differentiated thyroid cancer
por: Wong, K.T., et al.
Publicado: (2008) -
Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy
por: Grossrubatscher, Erika, et al.
Publicado: (2020)